| Literature DB >> 24298391 |
S R C Campos1, T C Melo, S Assaf, R P Araldi, J Mazzuchelli-de-Souza, M P Sircili, R F Carvalho, F Roperto, W Beçak, R C Stocco.
Abstract
THE MAJORITY OF MALIGNANT CELLS PRESENT GENETIC INSTABILITY WITH CHROMOSOME NUMBER CHANGES PLUS SEGMENTAL DEFECTS: these changes involve intact chromosomes and breakage-induced alterations. Some pathways of chromosomal instability have been proposed as random breakage, telomere fusion, and centromere fission. Chromosome alterations in tumor cells have been described in animal models and in vitro experiments. One important question is about possible discrepancies between animal models, in vitro studies, and the real events in cancer cells in vivo. Papillomaviruses are relevant agents in oncogenic processes related to action on host genome. Recently, many reports have discussed the presence of virus DNA in peripheral blood, in humans and in animals infected by papillomaviruses. The meaning of this event is of controversy: possible product of apoptosis occurring in cancer cells, metastasized cancer cells, or active DNA sequences circulating in bloodstream. This study compares chromosome aberrations detected in bovine cells, in peripheral blood cells, and in BPV lesion cells: the literature is poor in this type of study. Comparing chromosome aberrations described in the different cells, a common mechanism in their origin, can be suggested. Furthermore blood cells can be evaluated as an effective way of virus transmission.Entities:
Year: 2013 PMID: 24298391 PMCID: PMC3835608 DOI: 10.1155/2013/910849
Source DB: PubMed Journal: ISRN Oncol ISSN: 2090-5661
Figure 1Histological sections: (a) normal skin fragment, (b) cutaneous papilloma fragment, (c) esophagus papilloma fragment, and (d) fragment of papilloma collected from an urinary bladder of an animal affected by enzootic hematuria (HE) (10x).
Figure 2Example of BPV DNA sequences detected in cutaneous lesions and in respective primary culture cells: the samples were collected from one of the animals. I primers FAP59/64, II BPV2 specific primers. C− negative control, C+ positive control, A-B PCR with DNA from papilloma lesion, C–E primary cell culture using fragments from BPV positive lesion in passage 1, F–H primary cell culture using fragments from BPV positive lesion in passage 2, I-J primary cell culture using fragments from BPV positive lesion in passage 3, L primary cell culture using fragments from BPV positive lesion in passage 4, and M primary cell culture using fragments from BPV positive lesion in passage 5. It is important to pay attention in the different amplicons, suggesting possible different virus load.
Figure 3Primary cell cultures: (a) normal skin; (b) cutaneous papilloma; (c) esophagus papilloma; (d) papilloma of urinary bladder from animal affected with enzootic hematuria (10x). The arrow indicates a cell with a different morphology.
Chromosome aberration in peripheral blood cells and primary culture cells. C: control group; 1: cutaneous papillomatosis; 2: esophagus papillomas; 3: enzootic hematuria.
| Group | Total cells | % Numerical aberrations | % Structural aberrations§
| % Cells with gaps |
|---|---|---|---|---|
| Blood | ||||
| C | 126 | 7.86 ± 1.87 | 9.46 ± 0.97 | 3.93 ± 0.59 |
| 1 | 149 | 19.87 ± 4.59* | 30.89 ± 7.71* | 13.28 ± 4.50* |
| 2 | 101 | 26.32 ± 5.53* | 41.88 ± 2.25** | 11.29 ± 3.77* |
| 3 | 125 | 19.76 ± 4.69* | 33.89 ± 9.18* | 10.97 ± 1.92* |
|
| ||||
| Primary culture cells | ||||
| C | 124 | 14.43 ± 4.34 | 14.94 ± 1.85 | 7.16 ± 0.48 |
| 1 | 188 | 28.27 ± 3.14* | 40.39 ± 1.40** | 12.22 ± 4.48 |
| 2 | 164 | 46.39 ± 19.25¤ | 30.83 ± 0.37** | 13.81 ± 0.67** |
| 3 | 91 | 60.39 ± 0.55** | 28.46 ± 1.35** | 10.17 ± 3.92 |
*P≥ 0.05; **P≥ 0.01; ¤ P≥ 0.1; §cells presenting only gaps were evaluated isolate.
Frequencies of different aberrations detected in blood and primary culture cells of animals affected by cutaneous papillomas, esophagus papilloma, and enzootic hematuria.
| Blood | |||||
|---|---|---|---|---|---|
| Group | CA | AT | AF | CB | CrB |
|
| |||||
| C | 0.88 ± 1.24 | 2.48 ± 1.46 | 2.33 ± 0.81 | 1.75 ± 2.48 | 1.60 ± 0.22 |
| 1 | 4.27 ± 2.20¤ | 3.86 ± 0.96 | 7.20 ± 5.27 | 2.31 ± 2.00 | 8.67 ± 3.03* |
| 2 | 6.07 ± 1.28* | 6.34 ± 5.67 | 14.74 ± 1.11* | 1.16 ± 1.64 | 4.35 ± 3.71 |
| 3 | 1.65 ± 0.39 | 4.25 ± 2.14 | 6.86 ± 3.89 | 0.68 ± 0.97 | 6.31 ± 0.76** |
|
| |||||
| Ad/Del | EcrS | Aneu | Polip | Gaps | |
|
| |||||
| C | 2.33 ± 0.81 | 0.72 ± 1.02 | 7.86 ± 1.19 | 0.72 ± 1.02 | 3.93 ± 0.59 |
| 1 | 15.02 ± 3.04** | 2.85 ± 2.55 | 17.10 ± 3.57* | 2.77 ± 1.02¤ | 17.81 ± 4.97* |
| 2 | 26.28 ± 4.28** | 11.55 ± 3.18* | 23.14 ± 3.46* | 3.19 ± 2.07 | 14.17 ± 2.98* |
| 3 | 20.03 ± 7.02* | 12.34 ± 3.86* | 16.74 ± 6.24¤ | 3.02 ± 1.55 | 13.99 ± 3.46* |
|
| |||||
| Primary culture | |||||
|
| |||||
| Group | CA | AT | AF | CB | CrB |
|
| |||||
| C | 1.25 ± 1.77 | 3.01 ± 1.04 | 1.14 ± 1.61 | 0.63 ± 0.88 | 1.14 ± 1.61 |
| 1 | 5.61 ± 3.43¤ | 8.80 ± 3.50¤ | 5.79 ± 2.81¤ | 0.86 ± 0.75 | 5.59 ± 1.78* |
| 2 | 5.16 ± 1.02* | 4.74 ± 0.43¤ | 5.43 ± 1.74¤ | 0.42 ± 0.59 | 4.74 ± 0.42* |
| 3 | 3.21 ± 1.01 | 7.94 ± 2.91¤ | 3.48 ± 2.15 | 2.23 ± 0.38¤ | 2.23 ± 0.38 |
|
| |||||
| Ad/Del | EcrS | Aneu | Polip | Gaps | |
|
| |||||
| C | 7.67 ± 2.01 | 5.28 ± 2.17 | 13.81 ± 3.46 | 0.63 ± 0.88 | 8.30 ± 1.12 |
| 1 | 32.59 ± 7.82* | 9.95 ± 4.73 | 23.66 ± 6.13¤ | 3.57 ± 4.29 | 13.61 ± 5.73 |
| 2 | 26.36 ± 0.44** | 3.63 ± 1.99 | 38.70 ± 23.83 | 7.68 ± 4.58¤ | 18.97 ± 1.69** |
| 3 | 18.55 ± 1.49* | 5.71 ± 2.53 | 52.72 ± 0.31* | 6.42 ± 2.01* | 13.11 ± 0.87* |
*P > 0.05, **P > 0.01, and ¤ P ≥ 0.1.
CA: centromere association, AT: association of telomere, AF: acentric fragments, CB: chromosome break, CrB: chromatid break, Ad/Del: addition/deletion, EcrS: early chromatid separation, Aneu: aneuploidy, Polip: polyploidy, and gaps.
Figure 4Chromosome aberrations in primary culture cells ((a), (c), (e), and (g)) and peripheral lymphocytes ((b), (d), (f), and (h)): acentric fragments ((a), (b)); chromosome break (c); chromatid break (d); chromosome rearrangement with addition/deletion ((e), (f)); telomeric association (g), centromeric association ((e), (h)); early chromatid separation (thin arrow in (a), (e)).